October Pharma posts 20% YoY profit increase in Q1 2024

Updated 5/27/2024 12:00:00 PM
October Pharma posts 20% YoY profit increase in Q1 2024

Arab Finance: October Pharma’s (OCPH) net profits after tax surged 20.2% year on year (YoY) during the first quarter (Q1) of 2024, according to a financial statement.

The company recorded EGP 50.134 million in net profits in Q1 2024, up from EGP 41.711 million in Q1 2023.

Meanwhile, net sales jumped to EGP 274.414 million from EGP 212.655 million.

October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations.

The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.

Related News